FTO was described to promote the progression of diabetic nephropathy (Sun et al., 2022), and several SNPs in the FTO gene were associated with a significantly lower risk of nephropathy in T2DM patients (Montesanto et al., 2018). This evidence concerns the gene FTO and kidney disorder.